Literature DB >> 29361268

Gamma Ventral Capsulotomy in Intractable Obsessive-Compulsive Disorder.

Steven A Rasmussen1, Georg Noren2, Benjamin D Greenberg3, Richard Marsland3, Nicole C McLaughlin3, Paul J Malloy3, Stephen P Salloway3, David R Strong4, Jane L Eisen3, Michael A Jenike4, Scott L Rauch4, Lee Baer4, Christer Lindquist5.   

Abstract

BACKGROUND: Despite the development of effective pharmacologic and cognitive behavioral treatments for obsessive-compulsive disorder (OCD), some patients continue to be treatment-refractory and severely impaired. Fiber tracts connecting orbitofrontal and dorsal anterior cingulate cortex with subcortical nuclei have been the target of neurosurgical lesions as well as deep brain stimulation in these patients. We report on the safety and efficacy of ventral gamma capsulotomy for patients with intractable OCD.
METHODS: Fifty-five patients with severely disabling, treatment-refractory OCD received bilateral lesions in the ventral portion of the anterior limb of the internal capsule over a 20-year period using the Leksell Gamma Knife. The patients were prospectively followed over 3 years with psychiatric, neurologic, and neuropsychological assessments of safety and efficacy, as well as structural neuroimaging.
RESULTS: Thirty-one of 55 patients (56%) had an improvement in the primary efficacy measure, the Yale-Brown Obsessive Compulsive Scale, of ≥35% over the 3-year follow-up period. Patients had significant improvements in depression, anxiety, quality of life, and global functioning. Patients tolerated the procedure well without significant acute adverse events. Five patients (9%) developed transient edema that required short courses of dexamethasone. Three patients (5%) developed cysts at long-term follow-up, 1 of whom developed radionecrosis resulting in an ongoing minimally conscious state.
CONCLUSIONS: Gamma Knife ventral capsulotomy is an effective radiosurgical procedure for many treatment-refractory OCD patients. A minority of patients developed cysts at long-term follow-up, 1 of whom had permanent neurological sequelae.
Copyright © 2017 Society of Biological Psychiatry. All rights reserved.

Entities:  

Keywords:  Anterior capsulotomy; Efficacy; Frontostriatal circuits; Gamma Knife; Obsessive-compulsive disorder; Safety

Mesh:

Year:  2017        PMID: 29361268     DOI: 10.1016/j.biopsych.2017.11.034

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  19 in total

1.  Exploring the neurobiology of OCD: clinical implications.

Authors:  Jon E Grant; Samuel R Chamberlain
Journal:  Psychiatr Times       Date:  2020-03-02

Review 2.  The prefrontal cortex and neurosurgical treatment for intractable OCD.

Authors:  Steven A Rasmussen; Wayne K Goodman
Journal:  Neuropsychopharmacology       Date:  2021-08-25       Impact factor: 7.853

3.  Common and differential connectivity profiles of deep brain stimulation and capsulotomy in refractory obsessive-compulsive disorder.

Authors:  Xiaoyu Chen; Zhen Wang; Qian Lv; Qiming Lv; Guido van Wingen; Egill Axfjord Fridgeirsson; Damiaan Denys; Valerie Voon; Zheng Wang
Journal:  Mol Psychiatry       Date:  2021-10-26       Impact factor: 15.992

4.  Deep Brain Stimulation for Intractable Obsessive-Compulsive Disorder and Treatment-Resistant Depression.

Authors:  Benjamin M Borron; Darin D Dougherty
Journal:  Focus (Am Psychiatr Publ)       Date:  2022-01-25

5.  Predicting response to psychiatric surgery: a systematic review of neuroimaging findings.

Authors:  Benjamin Davidson; Hrishikesh Suresh; Maged Goubran; Jennifer S Rabin; Ying Meng; Karim Mithani; Christopher B Pople; Peter Giacobbe; Clement Hamani; Nir Lipsman
Journal:  J Psychiatry Neurosci       Date:  2020-11-01       Impact factor: 6.186

6.  Anterior limb of the internal capsule tractography: relationship with capsulotomy outcomes in obsessive-compulsive disorder.

Authors:  Chencheng Zhang; Seung-Goo Kim; Jun Li; Yingying Zhang; Qiming Lv; Kristina Zeljic; Hengfen Gong; Hongjiang Wei; Wenjuan Liu; Bomin Sun; Zheng Wang; Valerie Voon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-01-18       Impact factor: 10.154

7.  Magnetic resonance-guided focused ultrasound capsulotomy for refractory obsessive compulsive disorder and major depressive disorder: clinical and imaging results from two phase I trials.

Authors:  Benjamin Davidson; Clement Hamani; Jennifer S Rabin; Maged Goubran; Ying Meng; Yuexi Huang; Anusha Baskaran; Sachie Sharma; Miracle Ozzoude; Margaret Anne Richter; Anthony Levitt; Peter Giacobbe; Kullervo Hynynen; Nir Lipsman
Journal:  Mol Psychiatry       Date:  2020-05-14       Impact factor: 15.992

8.  Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorder.

Authors:  Christopher Pittenger; Brian P Brennan; Lorrin Koran; Carol A Mathews; Gerald Nestadt; Michele Pato; Katharine A Phillips; Carolyn I Rodriguez; H Blair Simpson; Petros Skapinakis; Dan J Stein; Eric A Storch
Journal:  Psychiatry Res       Date:  2021-03-04       Impact factor: 11.225

9.  Magnetic Resonance Imaging-Guided Laser Thermal Ventral Capsulotomy for Intractable Obsessive-Compulsive Disorder.

Authors:  Nicole C R McLaughlin; Peter M Lauro; Morgan T Patrick; Francesco G Pucci; Adriel Barrios-Anderson; Benjamin D Greenberg; Steven A Rasmussen; Wael F Asaad
Journal:  Neurosurgery       Date:  2021-05-13       Impact factor: 4.654

10.  Double blind randomized controlled trial of deep brain stimulation for obsessive-compulsive disorder: Clinical trial design.

Authors:  Nicole C R McLaughlin; Darin D Dougherty; Emad Eskandar; Herbert Ward; Kelly D Foote; Donald A Malone; Andre Machado; William Wong; Mark Sedrak; Wayne Goodman; Brian H Kopell; Fuad Issa; Donald C Shields; Osama A Abulseoud; Kendall Lee; Mark A Frye; Alik S Widge; Thilo Deckersbach; Michael S Okun; Dawn Bowers; Russell M Bauer; Dana Mason; Cynthia S Kubu; Ivan Bernstein; Kyle Lapidus; David L Rosenthal; Robert L Jenkins; Cynthia Read; Paul F Malloy; Stephen Salloway; David R Strong; Richard N Jones; Steven A Rasmussen; Benjamin D Greenberg
Journal:  Contemp Clin Trials Commun       Date:  2021-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.